Get Free Access
TZ Ref No.: TZ-1023925
Contract Award Awarded Contract 🌍 International (ICB) Czechia Pharmaceuticals Healthcare and Medicine Chemicals

Antineoplastics and immunomodulators 2026-II Cytostatic drug containing the active substance fludarabine

Doc ref no. 00622732-2026
Sector Pharmaceuticals, Healthcare and Medicine, Chemicals
Contract Date 11 Sep 2026
Contract Value Undisclosed
Contract Intelligence
AI opportunity notes and scope analysis for this contract award

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

Sign in to unlock Bid Fit & AI Opportunity Intelligence

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Contract Description

Antineoplastics and immunomodulators 2026-II Cytostatic drug containing the active substance fludarabine
Ampoules containing 50 mg of fludarabine, estimated annual volume of 320 ampoules (doses); ATC L01BB05

Days to Deadline
54 days
Closing: 10 Dec 2026, 00:00

Consortium & JV Partners

Matched
Need a Co-Bidder or Subcontractor?

Forming a Joint Venture increases technical eligibility and financial bonding capacity.

Post / Find JV Partners →

Key Contract Details

Doc ref no. 00622732-2026
Notice Type Contract Award
Contract CPV 38116000, 38000000, 24160000
Contract Project Location Czechia
Contract Value Undisclosed
Contract Date 11 Sep 2026
Contract Deadline 10 Dec 2026

Buyer Contact Information

Contact Details Locked

Nodal officer email, telephone, and website coordinates are unlocked upon free sign up.

Unlock Contact Details (Free) →